Why is JSS a strategic partner for your COVID-19 study development?

JSS COVID-19 Task Force


  • We have designated a team which keeps abreast of the latest developments pertaining to SARS-CoV-2

  • We have a deep understanding and are fully aware of the challenges involved in the current treatment processes and testing protocols according to the regulations of various states and provinces

  • Scientific Affairs Group
    • COVID-19 Standard of Care and Competing Studies
    • COVID-19 Synopsis and Protocol Templates

  • Feasibility
    • We are securing potential sites
    • We are remaining up-to-date with changing patient availability
    • We are aware of differentiations between Hospitals (Canada vs US), CHSLDs, Long-Term Care facilities and SMOs

With science and clinical epidemiological expertise at its core, JSS Medical Research is a leader in Post-Approval Clinical Epidemiology Studies (PACES) including Post-Marketing Observational Studies, Health Outcomes Research and Health Economics. Currently JSS Medical Research is conducting research studies in over 20 countries around the world for its clients which include 13 of the top 25 international Pharmaceutical companies.

We have been able to leverage our unique knowledge and experience in conducting post-approval studies for the Canadian affiliates of multinational pharmaceutical companies, to successfully designing and conducting global mandates for many of the the parent organizations.